Colon-specific delivery of 5-fluorouracil from zinc pectinate pellets through In Situ intracapsular ethylcellulose-pectin plug formation

Journal of Pharmaceutical Sciences

Volumn 102, Issue 2, 2013, Pages 604-616

  Elyagoby, A ^a   Layas, N ^a   Wong, T W ^a  

^a UNIVERSITI TEKNOLOGI MARA   (Malaysia)

Author keywords

5 fluorouracil; Colonic drug delivery; Dissolution; Ethylcellulose; Formulation; intracapsular coating; Pectin; Polymeric drug carrier; Site specific delivery

Indexed keywords

ETHYL CELLULOSE; EXCIPIENT; FLUOROURACIL; GELATIN; PECTIN; UNCLASSIFIED DRUG; ZINC PECTINATE;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL BINDING; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PELLET; DRUG RELEASE; DRUG SOLUBILITY; FILM COATING; IMMERSION; MOLECULAR WEIGHT; NONHUMAN; PARTICLE SIZE; POWDER; RAT; UPPER GASTROINTESTINAL TRACT;

EID: 84872499029     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23388     Document Type: Article

References (27)

1. Wong TW, Colombo G, Sonvico F. 2011. Pectin matrix as oral drug delivery vehicle for colon cancer. AAPS PharmSciTech 12:201-214.
2. Watts PJ, Illum L. 1997. Colonic drug delivery. Drug Dev Ind Pharm 23(9):893-913.
3. Vandamme ThF, Lenourry A, Charrueau C, Chaumeil J.C. 2002. The use of polysaccharides to target drugs to the colon. Carbohydr Polym 48:219-231.
4. Singh BN. 2007. Modified release solid formulations for colonic delivery. Recent Pat Drug Deliv Formul 1:53-63.
5. Sinha VR, Kumria R. 2003. Microbially triggered drug delivery to the colon. Eur J Pharm Sci 18:3-18.
6. Sinha VR, Kumria R. 2001. Polysaccharides in colon specific drug delivery. Int J Pharm 224:19-38.
7. Yang L, Chu JS, Fix JA. 2002. Colon-specific drug delivery, new approaches and in vitro/in vivo evaluation. Int J Pharm 235:1-15.
8. May CD. 2003. Pectins. In Handbook of hydrocolloids; Phillips GO, Williams PA, Eds. Cambridge, UK: Woodhead Publishing Limited, pp 169-188; Chapter 10.
9. Ridley BL, O'Neill MA, Mohnen D. 2001. Pectins: Structure, biosynthesis, and oligogalacturonide-related signalling. Phytochem 57:929-967.
10. Nakahara S, Raz A. 2007. Regulation of cancer-related gene expression by galectin-3 and the molecular mechanism of its nuclear import pathway. Cancer Metastasis Rev 26:605-610.
11. Jacobasch G, Dongowski G, Florian S, Müller-Schmehl K, Raab B, Schmiedl D. 2008. Pectin does not inhibit intestinal carcinogenesis in APC-deficient Min/ +mice. J Agri Food Chem 56(4):1501-1510.
12. Glinsky VV, Raz A. 2009. Modified citrus pectin anti-metastatic properties: One bullet, multiple targets. Carbohydr Res 344:1788-1791.
13. Hayashi A, Gillen AC, Lott JR. 2000. Effects of daily oral administration of quercetin chalcone and modified citrus pectin on implanted colon-25 tumour growth in balb-c mice. Altern Med Rev 5(6):546-552.
14. Nangia-Makker P, Hogan V, Honjo Y, Baccarini S, Tait L, Bresalier R, Raz A. 2002. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. J Natl Cancer Inst 94(24):1854-1862.
15. Olano-Martin E, Rimbach GH, Gibson GR, Rastall RA. 2003. Pectin and pecticoligosaccharides induce apoptosis in in vitro human colonic adenocarcinoma cells. Anticancer Res 23(1A):341-346.
16. Heitman DW, Hardman WE, Cameron IL. 1992. Dietary supplementation with pectin and guar gum on 1, 2 dimethylhydrazine-induced colon carcinogenesis in rats. Carcinogenesis 13(5):815-818.
17. Umar S, Morris AP, Kourouma F, Sellin JH. 2003. Dietary pectin and calcium inhibit colonic proliferation in vivo by differing mechanisms. Cell Prolif 36(6):361-375.
18. Dongowski G, Anger H. 1996. Metabolism of pectin in the gastrointestinal tract. In Pectins and pectinases; Visser J, Voragen AGJ, Eds. Amsterdam, The Netherlands: Elsevier, pp 659-666.
19. Saito D, Nakaji S, Fukuda S, Shimoyama T, Sakamoto J, Sugawara K. 2005. Comparison of the amount of pectin in the human terminal ileum with the amount of orally administered pectin. Nutrition 21:914-919.
20. Semdé R, Amighi K, Devleeschouwer MJ, Moës AJ. 2000. Effect of pectinolytic enzymes on the theophylline release from pellets coated with water insoluble polymers containing pectin HM or calcium pectinate. Int J Pharm 197:169-179.
21. Costa P, Lobo JMS. 2001. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 13:123-133.
22. Wei H, Qing D, De-Ying C, Bai X, Li-Fang F. 2008. Study on colon-specific pectin/ethylcellulose film-coated 5-fluorouracil pellets in rats. Int J Pharm 348:35-45.
23. Atyabi F, Majzoob S, Iman M, Salehi M, Dorkoosh F. 2005. In vitro evaluation and modification of pectinate gel beads containing trimethyl chitosan, as a multi-particulate system for delivery of water-soluble macromolecules to colon. Carbohydr Polym 61(1):39-51.
24. Wakerly Z, Fell JT, Attwood D, Parkins D. 1997. Studies on drug release from pectin/ethylcellulose film-coated tablets: A potential colonic delivery system. Int J Pharm 153:219-224.
25. Semdé R, Amighi K, Pierre D, Devleeschouwer MJ, Moës AJ. 1998. Leaching of pectin from mixed pectin/insoluble polymer films intended for colonic drug delivery. Int J Pharm 174:233-241.
26. Luo Y, Zhu J, Ma Y, Zhang H. 2008. Dry coating, a novel coating technology for solid pharmaceutical dosage forms. Int J Pharm 358:16-22.
27. Krishnaiah YSR, Satyanarayana V, Dinesh Kumar B, Karthikeyan RS, Bhaskar P. 2003. In vivo pharmacokinetics in human volunteers: Oral administered guar gum-based colon-targeted 5-fluorouracil tablets. Eur J Pharm Sci 19:355-362.